1. IC‐P‐015: Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials. (1st July 2013) Authors: Margolin, Richard; Schmidt, Mark; Gregg, Keith; Les, Andrea; Hill, Derek; Koeppe, Robert; Wyman, Bradley; Styren, Scot; Grundman, Michael; Yuen, Eric; Brashear, Robert H.; Liu, Enchi Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 1 Page Start: P18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Investigations into methods to improve the antibacterial activity of Acticoat. Issue 5 (1st May 2016) Authors: Ravensdale, Joshua; Wood, Fiona; O'Brien, Francis; Gregg, Keith Journal: Journal of medical microbiology Issue: Volume 65:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O1–06–02: Effect of bapineuzumab on CSF p‐tau and t‐tau in mild‐to‐moderate Alzheimer's disease: Results from two phase III trials in APOE‐ε4 carriers and noncarriers. (1st July 2013) Authors: Streffer, Johannes; Blennow, Kaj; Salloway, Stephen; Zetterberg, Henrik; Xu, Yi‐Zheng; Lu, Yuan; Lull, Julia; Collins, Peter; Tudor, Iulia Cristina; Gregg, Keith; Styren, Scot; Yuen, Eric; Grundman, Michael; Brashear, Robert H.; Liu, Enchi Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 3 Page Start: P138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1–352: The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab. (1st July 2013) Authors: Novak, Gerald; Einstein, Steven; Tudor, Iulia Cristina; Gregg, Keith; Collins, Peter; Wyman, Bradley; Yuen, Eric; Nielsen, Casper; Grundman, Michael; Brashear, Robert H.; Fox, Nick; Liu, Enchi Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 7 Page Start: P287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1–356: Correlation of brain atrophy with clinical progression in mild‐to‐moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab. (1st July 2013) Authors: Novak, Gerald; Einstein, Steven; Lu, Yuan; Tudor, Iulia Cristina; Gregg, Keith; Collins, Peter; Wyman, Bradley; Yuen, Eric; Nielsen, Casper; Grundman, Michael; Brashear, Robert H.; Fox, Nick; Liu, Enchi Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 7 Page Start: P289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P4–417: Incidence and clinical progression of placebo‐treated amyloid‐negative subjects with mild‐to‐moderate Alzheimer's disease (AD): Results from the phase III PET substudies of bapineuzumab and solanezumab. (1st July 2013) Authors: Salloway, Stephen; Sperling, Reisa; Gregg, Keith; Yu, Peng; Joshi, Abhinay; Lu, Ming; Mintun, Mark; Pontecorvo, Michael; Booth, Kevin; Wyman, Bradley; Sun, Jia; Sundell, Karen; Schmidt, Mark; Margolin, Richard; Skovronsky, Daniel; Liu, Enchi; Siemers, Eric; Brashear, Robert H. Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 22 Page Start: P888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗